Official Louisiana State Websites use .la.gov 
Secure .gov websites use HTTPS 
Newborn Screening Laboratory
Newborn screening (NBS) is a public health population based screening system designed to detect and treat infants with special needs who have certain hematologic, endocrine or metabolic disorders. The goal of newborn screening is to eliminate or reduce mortality, morbidity and disabilities that result from the disorders included in the screening panel through early detection and treatment. Early detection of these disorders can prevent the infant from having seizures, physical disabilities, mental retardation, chronic illness or death. By obtaining a few drops of blood from an infant's heel, tests are performed to help find the conditions so treatment can begin early and prevent these effects.
As of July 1, 2007, Louisiana is screening for all disorders recommended by the American College of Medical Genetics (ACMG). For more information on Newborn Screening, please click on the links below:
Secure Remote Viewer (SRV) Electronic Lab Results Registration - September 27, 2018
Due to updates in our policies to comply with regulatory requirements, all newborn
screening specimens must have a Hospital ID/Medical Record/Clinic ID Number provided
on the forms as the second unique patient identifier.
Beginning March 1, 2023 we will no longer call to obtain this information and we
cannot add the information to the form. This practice would be considered relabeling
of the specimen which is not allowed by laboratory regulations. If the second
identifier is missing, the specimen will not be tested and will need to be
recollected and resubmitted with the complete information included on the form.
***Effective 7 a.m. on June 14, 2022, the Secure Remote Viewer (SRV), used to
retrieve newborn screening results, will only be accessible by Chrome, Firefox or
Edge web browsers. Users are encouraged to download one of these browsers to access
SRV since Internet Explorer will no longer support Windows 10.
If there are any issues accessing the system after this date, please contact the
Genetic Diseases Program at 504-568-8254.***